Related Experiment Video
Updated: Aug 29, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a
J Eduardo Rame1, Marlon Ramilo, Nali Spencer
1Cardiovascular Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.
Insights
Concentric left ventricular hypertrophy can progress to heart failure. In hypertensive patients with normal ejection fraction, 18% developed reduced ejection fraction over 4 years, linked to coronary artery disease or pulmonary edema.
Area of Science:
- Cardiology
- Heart Failure Research
- Hypertension Studies
Background:
- The transition from left ventricular (LV) hypertrophy to heart failure is not fully understood.
- Concentric LV hypertrophy is a common adaptation to chronic pressure overload, particularly in hypertension.
- Identifying predictors of adverse outcomes in this population is crucial for clinical management.
Purpose of the Study:
- To define the progression of concentric left ventricular hypertrophy to heart failure in a cohort of hypertensive patients.
- To identify risk factors associated with the development of reduced ejection fraction (EF) in this population.
Main Methods:
- Prospective observational study.
- Inclusion of 159 predominantly African-American patients with hypertension and LV hypertrophy with normal ejection fraction (EF).
- Median follow-up of approximately 4 years to assess changes in EF.
Main Results:
- A significant proportion, 28 (18%) of patients, developed a reduced EF during the follow-up period.
- Key risk factors for developing reduced EF included a history of coronary artery disease, presence of pulmonary edema on chest x-ray, and subsequent myocardial infarction.
Conclusions:
- Concentric left ventricular hypertrophy in hypertensive patients with preserved ejection fraction carries a substantial risk of progression to heart failure.
- Coronary artery disease, pulmonary edema, and myocardial infarction are important clinical indicators predicting this adverse progression.
Abstract:
The progression from concentric left ventricular (LV) hypertrophy to heart failure has not been well defined. Of 159 predominantly hypertensive African-American patients with LV hypertrophy and a normal ejection fraction (EF), 28 (18%) developed a reduced EF after a median follow-up of approximately 4 years. Risk factors for this outcome included a history of coronary artery disease, pulmonary edema seen on a chest x-ray, or a subsequent myocardial infarction.
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pathophysiology of Heart Failure
Mitral Stenosis I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction
